Sort
21,281 grants matching “influenza”
Immunological mechanism of muscle-localizing self-replicating RNA vaccines
$1,090,789Taishi Kimura · Hdt Bio Corporation · R01 · FY2025 · AI
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$1,090,680Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Universal room temperature stable influenza nanovaccine
$1,090,313Balaji Narasimhan · Iowa State University · R01 · FY2022 · AI
Discrimination of nonself by innate immune receptors
$1,088,811Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Oklahoma Center for Respiratory and Infectious Diseases
$1,088,733Lin Liu · Oklahoma State University Stillwater · P30 · FY2024 · GM
Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells
$1,088,630Jacques F Banchereau · Jackson Laboratory · U01 · FY2019 · AI
Respiratory Virus Vaccine and Adjuvant Exploration - Equipment Supplement
$1,088,512Ralph S Baric · Univ Of North Carolina Chapel Hill · U01 · FY2020 · AI
PUBLIC HELATH EMERGENCY RESPONSE (PHER) - PANDEMIC INFLUENZA PREPARATION AND RES
$1,087,668Katrina Hedberg · Public Health Services · H75 · FY2010 · TP
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine
$1,087,654Pamuk Bilsel · Flugen, Inc. · R42 · FY2018 · AI
Virtual Patient Cohorts to Illuminate Immunologic Drivers of Influenza Severity
$1,087,528Amber M Smith · University Of Tennessee Health Sci Ctr · R01 · FY2025 · AI
Differentiation of Common Respiratory Viruses and SARS
$1,086,392Mark Aaron Poritz · Biofire Defense, Llc. · U01 · FY2006 · AI
Genomics Core
$1,086,064Christopher W Benner · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$1,085,867Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2025 · AI
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$1,085,473Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Omics-Based Predictive Modeling of Age-Dependent Outcome to Influenza Infection
$1,085,183Elodie Ghedin · University Of Pittsburgh At Pittsburgh · U01 · FY2013 · AI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population
$1,085,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2012 · IP
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research
$1,085,000Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2013 · IP
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population
$1,085,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2013 · IP
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research
$1,085,000Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2012 · IP
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
$1,085,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2012 · IP
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population
$1,085,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2011 · IP
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research
$1,084,999Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2011 · IP
Point-of-care Diagnosis and Surveillance of Known and Emerging Influenza Viruses
$1,083,699Timothy M Rose · Seattle Children'S Hospital · R01 · FY2015 · AI
Genetic & structural basis for viral neutralization:Vaccinia and Influenza virus
$1,083,485James E Crowe · Vanderbilt University · N01 · FY2012 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Vaccine Trial for Influenza
$1,082,877Robert Frenck · Cincinnati Childrens Hosp Med Ctr · N01 · FY2019 · AI